Curcumin Supplement in Nonalcoholic Fatty Liver Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The purpose of this study is to investigate the effects of curcumin supplement on metabolic factors and hepatic fibrosis in nonalcoholic fatty liver patients with type 2 diabetes. Subjects will participate in 3 month, two group, randomized intervention, where one group (n=25) will take 1.5g/d curcumin and the other group (n=25) will take a placebo to compare differences in outcomes between the two groups.
Epistemonikos ID: 3b7e721025969c6f8fbe3769d1b820248673ef42
First added on: May 17, 2024